{
  "label": "clinical_signal_03_dx_vaccine_immunogenicity_030",
  "artifact_type": "distractor_episode",
  "artifact_id": "sha256:be5fc9c9f6a0376b9528e661e4376f8a9bee753590aeb8188ff4d3ba83270918",
  "input_ids": [
    "sha256:b4ba5337b06c8de68ac3315db1a4f6980c5bd48efd529c3914f30297d6afd329",
    "sha256:b9a5f4498416bfb2148e106e9d25ca838481bb56025a18e16baf31718f4ee4a2"
  ],
  "prompt_id": null,
  "model_config": null,
  "created_at": "2026-02-17T12:01:39.991246",
  "content": "## 2024-09-23 Daily Operations Summary\n\n### Enrollment\n- Total Enrolled: 126\n- Active: 115\n- Screen Failures Cumulative: 40\n- Withdrawals Cumulative: 11\n\n### Enrollment by Dose Group\n- Low Dose: 29\n- Mid Dose: 31\n- High Dose: 33\n- Placebo: 33\n\n### Immunogenicity By Group\n#### Low Dose\n- IgG Titer (GMU) Mean: 42.4\n- IgG Titer (GMU) SD: 6.0\n- IgM Titer (GMU) Mean: 16.3\n- IgM Titer (GMU) SD: 4.0\n- Neutralizing Ab ID50 Mean: 63.7\n- Neutralizing Ab ID50 SD: 10.0\n- CD4 Response (SFC/10^6) Mean: 109.0\n- CD4 Response (SFC/10^6) SD: 15.0\n- CD8 Response (SFC/10^6) Mean: 79.0\n- CD8 Response (SFC/10^6) SD: 11.0\n- Seroconversion Percentage: 12.6\n\n#### Mid Dose\n- IgG Titer (GMU) Mean: 74.5\n- IgG Titer (GMU) SD: 9.6\n- IgM Titer (GMU) Mean: 28.3\n- IgM Titer (GMU) SD: 6.4\n- Neutralizing Ab ID50 Mean: 119.2\n- Neutralizing Ab ID50 SD: 16.0\n- CD4 Response (SFC/10^6) Mean: 177.0\n- CD4 Response (SFC/10^6) SD: 24.0\n- CD8 Response (SFC/10^6) Mean: 117.0\n- CD8 Response (SFC/10^6) SD: 18.0\n- Seroconversion Percentage: 30.5\n\n#### High Dose\n- IgG Titer (GMU) Mean: 100.2\n- IgG Titer (GMU) SD: 13.2\n- IgM Titer (GMU) Mean: 38.5\n- IgM Titer (GMU) SD: 8.8\n- Neutralizing Ab ID50 Mean: 157.3\n- Neutralizing Ab ID50 SD: 22.0\n- CD4 Response (SFC/10^6) Mean: 228.0\n- CD4 Response (SFC/10^6) SD: 33.0\n- CD8 Response (SFC/10^6) Mean: 167.0\n- CD8 Response (SFC/10^6) SD: 24.0\n- Seroconversion Percentage: 38.4\n\n#### Placebo\n- IgG Titer (GMU) Mean: 13.5\n- IgG Titer (GMU) SD: 1.2\n- IgM Titer (GMU) Mean: 5.8\n- IgM Titer (GMU) SD: 0.8\n- Neutralizing Ab ID50 Mean: 13.9\n- Neutralizing Ab ID50 SD: 2.0\n- CD4 Response (SFC/10^6) Mean: 23.0\n- CD4 Response (SFC/10^6) SD: 3.0\n- CD8 Response (SFC/10^6) Mean: 16.0\n- CD8 Response (SFC/10^6) SD: 2.0\n- Seroconversion Percentage: 6.1\n\n### Injection Site Reactions\n- Pain Percentage: 60.2\n- Erythema Percentage: 24.2\n- Swelling Percentage: 14.1\n- Induration Percentage: 6.4\n- Mean Pain Duration (Hours): 33.5\n\n### Systemic Reactogenicity\n- Fever Percentage: 16.8\n- Fatigue Percentage: 37.2\n- Myalgia Percentage: 31.9\n- Headache Percentage: 18.9\n- Chills Percentage: 12.8\n\n### Safety Labs\n- WBC (K) Mean: 5.6\n- WBC (K) SD: 1.3\n- Lymphocyte Percentage Mean: 27.5\n- Lymphocyte Percentage SD: 4.9\n- Neutrophil Percentage Mean: 63.9\n- Neutrophil Percentage SD: 7.0\n- Platelets (K) Mean: 254\n- Platelets (K) SD: 43\n- CRP (mg/L) Mean: 3.4\n- CRP (mg/L) SD: 1.8\n- Hemoglobin (g/dL) Mean: 14.7\n- Hemoglobin (g/dL) SD: 1.0\n\n### Adverse Events\n- AE ID: VI-AE-3077, Description: arthralgia, Grade: 1, Relatedness: related, Resolved: true, Dose Group: mid_dose\n- AE ID: VI-AE-3067, Description: injection site pain, Grade: 1, Relatedness: possibly related, Resolved: true, Dose Group: mid_dose\n\n### Events\n- DSMB safety review teleconference completed\n- Serology samples shipped to central immunology lab\n\n### Notes\n- Week 30: Immunogenicity assessments on schedule. 126 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks.",
  "metadata": {
    "episode_type": "distractor",
    "theme": "vaccine_immunogenicity",
    "theme_index": 1,
    "local_index": 30,
    "scope_id": "clinical_signal_03",
    "layer_name": "distractor_episodes",
    "layer_level": 2,
    "build_fingerprint": {
      "scheme": "synix:build:v1",
      "digest": "86d399f4ea18a5663d6624e24cd8b639bcd4c45932ccbdc83c5254419dc5a8df",
      "components": {
        "transform": "a88665a5359d5ac5d2c858c77a2a19318c209adeea6fae2b838d79e11f6aba2b",
        "inputs": "c06ced136368edaf"
      }
    },
    "transform_fingerprint": {
      "scheme": "synix:transform:v2",
      "digest": "a88665a5359d5ac5d2c858c77a2a19318c209adeea6fae2b838d79e11f6aba2b",
      "components": {
        "transform_id": "01137a4997b78f86",
        "source": "c42d9c6282d5331f",
        "model": "1e2ccf75e96d7ee7"
      }
    }
  }
}